124 related articles for article (PubMed ID: 25661069)
1. Overexpression of phosphorylated 4E-binding protein 1 and its clinicopathological significances in gastric cancer.
Lee HW; Park MI; Kim MS; Kim SH; Roh MS; Kim K; Jung SB; Lee EH
Pathol Res Pract; 2015 Apr; 211(4):298-302. PubMed ID: 25661069
[TBL] [Abstract][Full Text] [Related]
2. Prognostic significance of phosphorylated 4E-binding protein 1 in non-small cell lung cancer.
Lee HW; Lee EH; Lee JH; Kim JE; Kim SH; Kim TG; Hwang SW; Kang KW
Int J Clin Exp Pathol; 2015; 8(4):3955-62. PubMed ID: 26097581
[TBL] [Abstract][Full Text] [Related]
3. Putative role of the mTOR/4E-BP1 signaling pathway in the carcinogenesis and progression of gastric cardiac adenocarcinoma.
Yang HY; Xue LY; Xing LX; Wang J; Wang JL; Yan X; Zhang XH
Mol Med Rep; 2013 Feb; 7(2):537-42. PubMed ID: 23229050
[TBL] [Abstract][Full Text] [Related]
4. Phosphorylated 4E-BP1 is associated with tumor progression and adverse prognosis in colorectal cancer.
Chen Y; Wang J; Fan H; Xie J; Xu L; Zhou B
Neoplasma; 2017; 64(5):787-794. PubMed ID: 28592131
[TBL] [Abstract][Full Text] [Related]
5. 4E binding protein 1 expression is inversely correlated to the progression of gastrointestinal cancers.
Martín ME; Pérez MI; Redondo C; Alvarez MI; Salinas M; Fando JL
Int J Biochem Cell Biol; 2000 Jun; 32(6):633-42. PubMed ID: 10785360
[TBL] [Abstract][Full Text] [Related]
6. The effect of p-4E-BP1 and p-eIF4E on cell proliferation in a breast cancer model.
Pons B; Peg V; Vázquez-Sánchez MA; López-Vicente L; Argelaguet E; Coch L; Martínez A; Hernández-Losa J; Armengol G; Ramon Y Cajal S
Int J Oncol; 2011 Nov; 39(5):1337-45. PubMed ID: 21750861
[TBL] [Abstract][Full Text] [Related]
7. High phosphorylated 4E-binding protein 1 expression after chemoradiotherapy is a predictor for locoregional recurrence and worse survival in esophageal squamous cell carcinoma patients.
Chao YK; Chuang WY; Yeh CJ; Chang YS; Wu YC; Kuo SY; Hsieh MJ; Hsueh C
J Surg Oncol; 2012 Mar; 105(3):288-92. PubMed ID: 21932407
[TBL] [Abstract][Full Text] [Related]
8. Expression of the eukaryotic translation initiation factor 4E (eIF4E) and 4E-BP1 in esophageal cancer.
Salehi Z; Mashayekhi F
Clin Biochem; 2006 Apr; 39(4):404-9. PubMed ID: 16375881
[TBL] [Abstract][Full Text] [Related]
9. Phosphorylated 4E-binding protein 1 (p-4E-BP1): a novel prognostic marker in human astrocytomas.
Korkolopoulou P; Levidou G; El-Habr EA; Piperi C; Adamopoulos C; Samaras V; Boviatsis E; Thymara I; Trigka EA; Sakellariou S; Kavantzas N; Patsouris E; Saetta AA
Histopathology; 2012 Aug; 61(2):293-305. PubMed ID: 22690797
[TBL] [Abstract][Full Text] [Related]
10. The 4E-BP1/eIF4E ratio is a determinant for rapamycin response in esophageal cancer cells.
Hsu HS; Lin MH; Jang YH; Kuo TT; Liu CC; Cheng TH
J Thorac Cardiovasc Surg; 2015 Jan; 149(1):378-85. PubMed ID: 25439783
[TBL] [Abstract][Full Text] [Related]
11. PC-1/PrLZ confers resistance to rapamycin in prostate cancer cells through increased 4E-BP1 stability.
Yu L; Shang ZF; Wang J; Wang H; Huang F; Zhang Z; Wang Y; Zhou J; Li S
Oncotarget; 2015 Aug; 6(24):20356-69. PubMed ID: 26011939
[TBL] [Abstract][Full Text] [Related]
12. Cell signaling in endometrial carcinoma: phosphorylated 4E-binding protein-1 expression in endometrial cancer correlates with aggressive tumors and prognosis.
Castellvi J; Garcia A; Ruiz-Marcellan C; Hernández-Losa J; Peg V; Salcedo M; Gil-Moreno A; Ramon y Cajal S
Hum Pathol; 2009 Oct; 40(10):1418-26. PubMed ID: 19428047
[TBL] [Abstract][Full Text] [Related]
13. Eukaryotic translation initiation factor 4E (eIF-4E) expressions are associated with poor prognosis in colorectal adenocarcinoma.
Chen YT; Tsai HP; Wu CC; Wang JY; Chai CY
Pathol Res Pract; 2017 May; 213(5):490-495. PubMed ID: 28242042
[TBL] [Abstract][Full Text] [Related]
14. Adenovirus-mediated eukaryotic initiation factor 4E binding protein-1 in combination with rapamycin inhibits tumor growth of pancreatic ductal adenocarcinoma in vivo.
Mishra R; Miyamoto M; Yoshioka T; Ishikawa K; Matsumura Y; Shoji Y; Ichinokawa K; Itoh T; Shichinohe T; Hirano S; Kondo S
Int J Oncol; 2009 May; 34(5):1231-40. PubMed ID: 19360336
[TBL] [Abstract][Full Text] [Related]
15. Mechanisms of GOLPH3 associated with the progression of gastric cancer: a preliminary study.
Peng J; Fang Y; Tao Y; Li K; Su T; Nong Y; Xie F; Lai M
PLoS One; 2014; 9(10):e107362. PubMed ID: 25286393
[TBL] [Abstract][Full Text] [Related]
16. Overexpression of p-4ebp1 in Chinese gastric cancer patients and its correlation with prognosis.
Jiao X; Pan J; Qian J; Luo T; Wang Z; Yu G; Wang J
Hepatogastroenterology; 2013 Jun; 60(124):921-6. PubMed ID: 23159388
[TBL] [Abstract][Full Text] [Related]
17. Expression of eukaryotic initiation factor 4E and 4E binding protein 1 in colorectal carcinogenesis.
Diab-Assaf M; Abou-Khouzam R; Saadallah-Zeidan N; Habib K; Bitar N; Karam W; Liagre B; Harakeh S; Azar R
Int J Clin Exp Pathol; 2015; 8(1):404-13. PubMed ID: 25755728
[TBL] [Abstract][Full Text] [Related]
18. A comprehensive immunohistochemical approach of AKT/mTOR pathway and p-STAT3 in mycosis fungoides.
Levidou G; Siakantaris M; Papadaki T; Papadavid E; Vassilakopoulos TP; Angelopoulou MK; Marinos L; Nikolaou V; Economidi A; Antoniou C; Patsouris E; Korkolopoulou P
J Am Acad Dermatol; 2013 Sep; 69(3):375-84. PubMed ID: 23685026
[TBL] [Abstract][Full Text] [Related]
19. Phosphorylated 4E-binding protein 1 expression is associated with poor prognosis in small-cell lung cancer.
Roh MS; Lee JH; Kang KW; Nam HY; Jung SB; Kim K; Lee EH; Park MI; Kim MS; Lee HW
Virchows Arch; 2015 Dec; 467(6):667-673. PubMed ID: 26445970
[TBL] [Abstract][Full Text] [Related]
20. Twist1-mediated 4E-BP1 regulation through mTOR in non-small cell lung cancer.
Lv T; Wang Q; Cromie M; Liu H; Tang S; Song Y; Gao W
Oncotarget; 2015 Oct; 6(32):33006-18. PubMed ID: 26360779
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
